Nuclear medicine and medical imaging, such as PET scans, have changed how many diseases (e.g., cancer, Alzheimer's) are evaluated and treated. Learn how USP is updating its standards to reflect “state-of-the-industry” practices in this field.
Learn about the evolving and challenging role of glycosylation analysis in biopharmaceutical science and how USP documentary and reference standards can support advances in this field.
October is Talk About Your Medicines Month. Sponsored by NCPIE, a USP Convention member organization, this annual opportunity encourages patients and healthcare providers to engage in conversation about medications and their safe use, safe storage, and safe disposal.
USP-China is working collaboratively with China’s local governments and other key stakeholders to advance the quality of medicines and food in China and globally.
Everything I have learned and worked toward for pretty much my entire scientific career culminates in the Chief Science Officer role at USP.
Margaret Hamburg is approaching the end of a successful six-year tenure as Commissioner of the U.S. Food and Drug Administration. USP extends its congratulations to Dr. Hamburg in this letter from CEO Ron Piervincenzi.
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) marked a major milestone in the fight against substandard and poor quality drugs by acheiving internationally recognized ISO 17025 accreditation.